Related Experiment Videos
125I brachytherapy k-edge dose enhancement with AgTPPS4
L A Young1, I J Kalet, J S Rasey
1Department of Bioengineering, University of Washington, Seattle 98195, USA. layoung@u.washington.edu
Medical Physics
|June 3, 1998
Summary
Silver tetraphenyl sulfonato porphyrin (AgTPPS4) can enhance radiation dose in tumors during brachytherapy. However, AgTPPS4 is cytotoxic at effective concentrations, necessitating further research for safe delivery.
Area of Science:
- Medical Physics
- Radiotherapy
- Materials Science
Background:
- Photon activation enhances radiation absorption via photoelectric interactions.
- Optimizing photoelectric interaction requires matching element binding energies with photon energies.
Purpose of the Study:
- To quantify the potential dose enhancement in tumors using silver tetraphenyl sulfonato porphyrin (AgTPPS4) as a photon activator.
- To evaluate AgTPPS4 for use with interstitial Iodine-125 (125I) brachytherapy.
Main Methods:
- Developed a 3D Monte Carlo dosimetry model using the EGS4 coding system.
- Modeled photon sources using spectral gamma emissions from 125I brachytherapy seeds (models 6702 or 6711).
- Calculated absorbed dose in tumors for AgTPPS4 concentrations from 0 to 20 mmol/kg.
Main Results:
- Demonstrated a linear increase in tumor absorbed dose with increasing AgTPPS4 concentration.
- Determined the required AgTPPS4 concentration (RSC) for a 10% dose increase is ~6.5 mmol/kg for model 6702 seeds.
- In vitro toxicity studies revealed AgTPPS4 is cytotoxic at effective concentrations.
Conclusions:
- AgTPPS4 shows theoretical potential for brachytherapy dose enhancement.
- The intrinsic cytotoxicity of AgTPPS4 at effective doses limits its current application.
- Development of a non-toxic delivery system for silver to tumor cells is required.